Repros Therapeutics Inc. halts clinical trial

Repros Therapeutics Inc. may face bankruptcy after suspending their clinical trials fro Proellex. The studies were postponed due to concerns for trial participants safety. The drug being tested treated chronic symptomatic uterine fibroids, anemia associated with this condition and endometriosis. Read the full article here.